Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cellular delivery of antisense oligonucleotides.

I Lebedeva1, L Benimetskaya, C A Stein

  • 1Columbia University, NY, New York, USA.

European Journal of Pharmaceutics and Biopharmaceutics : Official Journal of Arbeitsgemeinschaft Fur Pharmazeutische Verfahrenstechnik E.V
|June 7, 2000
PubMed
Summary

Antisense oligonucleotides can inhibit gene expression but struggle with cell entry. This review explores various delivery methods to enhance their effectiveness for therapeutic applications.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Muscadine Grape Skin Extract in Biochemically Recurrent Prostate Cancer: A Randomized, Placebo-Controlled, Biomarker-Enriched Trial in Patients With the SOD2 Ala/Ala Variant.

The Prostate·2025
Same author

A stress-induced response complex (SIRC) shuttles miRNAs, siRNAs, and oligonucleotides to the nucleus.

Proceedings of the National Academy of Sciences of the United States of America·2018
Same author

A cytoplasmic pathway for gapmer antisense oligonucleotide-mediated gene silencing in mammalian cells.

Nucleic acids research·2015
Same author

Metastatic adrenocortical carcinoma with a prolonged response to mitotane.

Oncology (Williston Park, N.Y.)·2014
Same author

A critical assessment of the potential of short interfering RNA therapeutics.

Drug discovery today. Technologies·2014
Same author

Development and antitumor activity of a BCL-2 targeted single-stranded DNA oligonucleotide.

Cancer chemotherapy and pharmacology·2014

Area of Science:

  • Molecular Biology
  • Biotechnology
  • Drug Delivery Systems

Background:

  • Antisense oligonucleotides (ASOs) are potent tools for gene silencing.
  • Polyanionic nature of many ASOs hinders passive cell membrane transit.
  • Challenges exist in interpreting data from naked oligonucleotide experiments.

Purpose of the Study:

  • To review and compare methods for improving intracellular delivery of antisense oligonucleotides.
  • To highlight the strengths and limitations of various oligonucleotide delivery vehicles.

Main Methods:

  • Discussion of cationic lipids for oligonucleotide delivery.
  • Exploration of protein and peptide-based delivery agents.
  • Review of novel chemical and viral delivery strategies.

Related Experiment Videos

Main Results:

  • Various methods enhance oligonucleotide delivery into cells and nuclei.
  • Each delivery method presents unique advantages and disadvantages.
  • Improved delivery is crucial for maximizing antisense technology performance.

Conclusions:

  • Effective delivery systems are essential for successful antisense oligonucleotide applications.
  • Ongoing research focuses on optimizing chemical and viral delivery methods.
  • Understanding delivery vehicle limitations is key to advancing antisense therapies.